Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06340178

CT-guided Lung Biopsy Risk Optimization Method

CT-guided Lung Biopsy Risk Optimization Method - Effect of Fluid Application in the Pleural Cavity and the Gravitational Effect of Pleural Pressure

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
198 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, in addition to patient positioning to allow biopsy in gravity-dependent areas of the lung.

Detailed description

Study participants with written consent and the percutaneous, CT-guided lung biopsy already regularly indicated by the referring doctors (e.g., oncology) will be part of this study and will be randomized directly before the intervention. After randomization, the intervention is performed by Interventional Radiology, either with or without prior fluid administration into the pleural space. Three samples are taken using either an 18G or 20G coaxial needle, and any complications are treated according to the clinical standard. The lung biopsy will be only performed if clinically indicated and is not a study-specific intervention; data about the lung biopsy, like internal DICOM images of them retrieved from Inselspital's Picture Archiving and Communication System (PACS), laboratory results, and clinical information are retrieved from RIS (radiological information system) and iPDOS® and KISS by Epic® (electronic medical record) and the associated histopathological findings from the Institute of Pathology, University of Bern, will be analyzed.

Conditions

Interventions

TypeNameDescription
PROCEDUREFluid application during ct-guided lung biopsyInjection of a small amount of fluid (max. 20 ml sodium chlorid) in the pleural cavity at the biopsy site

Timeline

Start date
2025-09-29
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2024-04-01
Last updated
2026-02-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06340178. Inclusion in this directory is not an endorsement.